Klonetics is pleased to announce the appointment of Natasha Shumka as the company's new Chief Operating Officer (COO), effective immediately. Natasha, who has been an invaluable member of the Klonetics team as the Quality Assurance Person (QAP) and Chief Strategy Officer (CSO), will now take on this pivotal leadership role. In her new capacity as COO, Natasha will assume responsibility for guiding and enhancing the company's operational functions. Her extensive experience with Global cannabis certifications, dedication to quality, and visionary approach make her the ideal candidate to lead Klonetics into a new era of growth and efficiency. Natasha brings a wealth of expertise to her role as COO. Her previous positions within the company have allowed her to intimately understand Klonetics' operations, strategy, and culture. This familiarity positions her to make immediate and impactful contributions to the organization. Natasha's primary focus as Chief Operating Officer will be to optimize operational efficiency, foster clear and effective communication channels, and ensure that the company's objectives are not only met, but exceeded. Her commitment to excellence and her ability to inspire and lead teams will play a crucial role in Klonetics' continued success. Natasha is currently in the midst of pursuing her QAGMP (Quality Assurance and Good Manufacturing Practices) diploma. Her goal is to complete this program successfully, and her efforts are all part of a broader plan to obtain Klonetic GMP (Good Manufacturing Practices) approval. This approval is significant because it will enable Klonetic to expand its international relationships in the cannabis industry. By ensuring high-quality production and compliance with internationally recognized standards, Natasha's diploma and her dedication to GMP will play a pivotal role in Klonetic's efforts to establish itself as a reputable and trusted player in the global cannabis market. Natasha Shumka's appointment as COO marks an exciting chapter in Klonetics' journey, and the company looks forward to achieving new goals, both here and abroad. Please join us in congratulating Natasha Shumka on her well-deserved promotion to Chief Operating Officer at Klonetics.

Today, we would like to share an important update regarding our executive leadership team. After thoughtful consideration, Tom Smale will no longer be fulfilling the role of Chief Operating Officer at Klonetics. Tom's departure comes as a result of a shared understanding that the demands of his other responsibilities have made it increasingly challenging for him to dedicate the 100% commitment we require from our C-level executives. Tom's passion and energy have been divided between Klonetics and his own ventures, and to ensure that we can continue to serve our customers and shareholders to the best of our abilities, we have made the difficult decision to part ways. We believe this decision is in the best interest of both Tom and the future of Klonetics. As many of you are aware, Klonetics has been experiencing significant growth and success over the past few months, not only here in Canada, but Internationally. For this reason, it is imperative that we have a leadership team that is able to give their full attention to this significant growth phase as our needs become greater, and our scale increases. Klonetics has bolstered our team, by adding a sophisticated and dedicated Cultivation Lead with an extensive background in the cannabis industry. Effective immediately, we are thrilled to announce that Natasha Shumka , who has been an integral part of our leadership team for the last 6 months, will assume the role of Chief Operating Officer. Natasha's dedication, expertise, and deep understanding of our company's strategic goals make her the ideal candidate to lead our operations as we continue on our path of growth and innovation. We are excited about the opportunities in front of us and are committed to delivering the same level of excellence and innovation that you have come to expect from Klonetics. We would like to express our deepest gratitude to Tom for his contributions at Klonetics over the past 15 months and wish him all the best with his future projects and adventures. Thank you for your continued support and trust in Klonetics as we continue to evolve and grow into a global cannabis company, backed by science.

Klonetics is proud to announce that we have successfully obtained our IMC GAP (Good Agricultural Practices) and GACP (Good Agricultural and Collection Practices) certifications. These prestigious certifications, recognized globally, reflect our continued dedication to cultivating the highest quality cannabis products while adhering to the strictest standards of safety, environmental responsibility, and sustainability.

We are thrilled to announce a major milestone in our journey to become a vertically integrated cannabis company serving the needs of the industry in Canada, and abroad. 2023 has been a remarkable year for Klonetics marked by significant milestones that have paved the way for our expansion and growth. Most recently, we secured a two year contract with a large licensed producer to custom grow premium craft cannabis. This partnership extends their market reach in the premium craft cannabis category and allows them to offer new and exciting cultivars. The deal will showcase the best genetics in the Klonetics library and demonstrate our commitment to superior quality plants meticulously nurtured from tissue to flower.

KELOWNA, BC, August 16, 2023 - Klonetics Plant Science Inc, the distinguished leader in the Canadian cannabis industry of pathogen-free cell-cultured cannabis clones, and Craft Nurseries Inc (CNC), a preeminent full-service nursery specializing in breeding and curating commercially viable cannabis cultivars, proudly unveil a strategic partnership aimed at jointly propelling the marketing and distribution of unparalleled genetics to licensed cultivators across global regions, including Canada, Israel, the European Union, Australia, and other international territories. CNC is a wholly-owned subsidiary of reporting issuer AgriCann Solutions Corp.

We are delighted to inform you that we have successfully received our cannabis processing license. This license grants us the authority to create, process and package a wide variety of cannabis products, allowing us to expand our operations and services to our valued clients.

In our continued pursuit of creating a globally accredited facility capable of exporting to every regulated cannabis market in the world, we are pleased to announce that we are currently pursuing our IMC-GAP certification.

The market has a tendency to sway in the same direction a lot, which helps us understand what’s popular, but does little for LPs looking to differentiate from competitors. Eventually market saturation happens, and LPs all start looking the same with the cultivars they’re putting out, which we’re seeing now with many of the dessert and gas strains. Introducing the Vi Mother Program. You don’t have to be limited by your in-house genetics. With our new Vi Mother Program, you can select any cultivar from our award-winning catalogue and have us grow your mother plants here on site for you. Add some fire to your roster! Select cultivars from our award-winning genetics catalogue We'll keep your designated mother plants healthy on site at Klonetics We’ll work with you to align with and plan your production Ask us about optional exclusivity. Available for 12 month terms. Live Plants (active) cultivars: Ready in 8 weeks Tissue Culture cultivars: Ready in 12 weeks (4 weeks - TC to Clone, 8 weeks - Clone to RTF) Contact our sales team today at info@klonetics.com

We are very pleased to announce our exclusive partnership with REMIX Genetics; a University of Guelph HUB Incubator company based in Ontario which allows us to offer select REMIX Genetics’ cultivars to our Canadian licensed producer customers. REMIX’s areas of expertise include strain development & breeding, cytological analysis, polyploid production, genetic imports (for R&D), and tissue culture assisted breeding. REMIX is applying modern agricultural science to advance the cannabis industry, including advanced approaches to plant phenotyping traditional genetics and developing new improved genetics with modern breeding techniques, including the first seedless cannabis in Canada. Seedless triploid cannabis was developed utilizing the same game changing technology that brought us seedless watermelons and bananas, and provides a 26% increase in yield and no potency loss. These cultivars also finish faster and because they produce 99% fewer seeds and save growers from losses due to unintentional pollination. This initial release includes three standard diploid cultivars developed specifically for greenhouse producers in mind. But make no mistake, they still pack a punch! Mango Crush, Sunset Glow, and Lemon Haze are the first REMIX cultivars available in the Klonetics catalogue for the Canadian market. We can't wait to collaborate further with REMIX Genetics to roll out some serious fire and seedless cultivars in the coming months ahead. Learn more about REMIX Genetics here: https://www.remixgenetics.ca/